CAELUM Co., Ltd. (KOSDAQ:258610)
1,397.00
-45.00 (-3.12%)
At close: Apr 23, 2026
CAELUM Revenue
In the year 2025, CAELUM had annual revenue of 81.70B KRW, down -16.06%. CAELUM had revenue of 11.58B in the quarter ending December 31, 2025, a decrease of -37.65%.
Revenue
81.70B
Revenue Growth
-16.06%
P/S Ratio
0.63
Revenue / Employee
2.15B
Employees
38
Market Cap
51.37B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 81.70B | -15.63B | -16.06% |
| Dec 31, 2024 | 97.33B | 12.78B | 15.12% |
| Dec 31, 2023 | 84.55B | 6.70B | 8.61% |
| Dec 31, 2022 | 77.84B | 24.92B | 47.09% |
| Dec 31, 2021 | 52.92B | 41.43B | 360.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nara Mold & Die | 184.63B |
| Next Entertainment World | 142.65B |
| BORATR CO. | 102.30B |
| Omnisystem | 99.07B |
| Bankware Global | 63.45B |
| Biotoxtech | 47.02B |
| Frtek Co.Ltd. | 25.26B |
| OBZEN | 22.37B |